Despite good results in PF cell pellets, other studies suggest that NGS on body fluid supernatants possesses higher performance for detecting EGFR mutations in cfDNA compared to body fluid sedimentary tumor cells and plasma cfDNA specimens [49]. This evidence concerns the gene EGFR and neoplasm.